Rochester, MN, United States of America

Lilach O Lerman

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lilach O Lerman: Innovator in Renal Therapeutics

Introduction

Lilach O Lerman is a prominent inventor based in Rochester, MN (US). She has made significant contributions to the field of renal therapeutics, holding two patents that focus on innovative methods for treating renal conditions. Her work is characterized by a commitment to improving patient outcomes through advanced medical solutions.

Latest Patents

Lilach's latest patents include groundbreaking methods for preventing and treating renal ischemia-reperfusion injury in mammalian subjects. These patents detail the use of aromatic-cationic peptides, which are administered to subjects in need of treatment. The methods aim to prevent or treat renal injury during the management of renal artery stenosis, showcasing her dedication to addressing critical health issues.

Career Highlights

Throughout her career, Lilach has worked with notable organizations such as Stealth Biotherapeutics Inc. and the Mayo Foundation for Medical Education and Research. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Lilach has collaborated with esteemed colleagues, including D Travis Wilson and Stephen C Textor. These partnerships have further enriched her research and innovation efforts, leading to impactful developments in renal therapies.

Conclusion

Lilach O Lerman stands out as a dedicated inventor whose work in renal therapeutics is paving the way for new treatment methodologies. Her innovative approach and collaboration with leading organizations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…